Urolithin A is a compound produced when gut bacteria metabolize ellagitannins, polyphenols found in pomegranates, walnuts, and certain berries. Its primary mechanism of interest is mitophagy activation: the cellular process of identifying and clearing damaged mitochondria so they can be replaced by healthier ones. This quality-control system tends to decline with age, and in early human studies urolithin A has shifted some muscle and mitochondrial biomarkers, though the main company-funded trials missed their primary endpoints [9][10][11][1].
As interest has grown, so has the supplement market, and not always with careful quality control. A 2024 laboratory analysis found notable discrepancies between the urolithin A amounts stated on product labels and the amounts actually present in tested supplements [2]. Understanding what to look for, and what questions to ask, can help you make a more informed decision than brand marketing alone allows.
Key Takeaways
- Not everyone can produce urolithin A from food; direct supplementation bypasses the need for specific gut bacteria [3].
- Label accuracy is a documented problem in the UA supplement category: independent third-party certificates of analysis are essential [2].
- Human safety and mechanistic data exist primarily for doses of 500 to 1000 mg per day; products with substantially lower doses have weaker scientific grounding [1].
- Liposomal and nanoparticle delivery formats have shown better stability in lab work, but published human data showing they raise urolithin A levels is thin, so treat “enhanced absorption” as a marketing claim unless the company shows pharmacokinetic data [14][15][4].
- Early evidence for mitochondrial and muscle benefits is mixed: the main trials missed their primary endpoints, and the one small heart-failure trial found no benefit [9][10][13][11]no UA product has been approved to treat or prevent disease [5].
What Urolithin A Does and Why Diet Alone May Not Be Enough
Urolithin A is not found directly in food. It is a postbiotic: a compound your intestinal microbiome synthesizes after processing ellagitannins from foods like pomegranate, walnuts, and raspberries [6]. The conversion requires specific bacterial strains, and research shows considerable variation between individuals, and in a trial of 100 healthy US adults, 33% could not convert pomegranate juice to urolithin A and another 27% converted it poorly [12][3].
This is the practical rationale for direct supplementation. If you cannot reliably produce UA yourself, eating more pomegranate seeds does not reliably raise circulating UA levels. Supplementing with pre-formed UA bypasses the microbial conversion step entirely. The tradeoff is that you are now dependent on the supplement actually containing what it claims, which, as discussed below, is not guaranteed.
The Mitophagy Mechanism: What the Science Actually Says
Mitochondria accumulate damage over time from oxidative stress and normal metabolic activity. Cells have a recycling system called mitophagy that tags and removes defective mitochondria; when this process is running well, it supports energy production, reduces cellular stress, and may slow aspects of age-related functional decline [7]. Urolithin A has been identified as one of the more studied natural activators of this pathway.
Research note: FDA states its food additive safety office did not evaluate any information in terms of labeling claims, so the GRAS response says nothing about the health benefits urolithin A products may claim [16].
A first-in-human safety trial found that 4 weeks of 500 mg and 1,000 mg urolithin A changed plasma acylcarnitines and muscle mitochondrial gene expression in elderly adults; these were secondary outcomes, so they are biomarker signals rather than proof of a clinical benefit [1]. The one small randomized heart-failure trial in the verified evidence (10 patients) found no significant change in heart function on echocardiogram, and its authors say the results do not support a benefit [13][5]. These findings are early-stage; they establish biological plausibility and measurable changes in biomarkers, but do not yet prove prevention or treatment of specific diseases.
Two company-funded trials of urolithin A missed their pre-specified primary endpoints (peak power on a cycling test in middle-aged adults; 6-minute walk distance and muscle ATP production in older adults), and a 2024 systematic review of five trials (250 people) found no effect on physical function [9][10][11].
The Label Accuracy Problem: A Real Reason for Scrutiny
One of the clearest reasons to scrutinize a UA supplement before purchasing it is label accuracy. A 2024 analysis that tested the actual content of urolithin A products against their stated label claims found that many products did not match what was printed on the bottle [2]. Some contained significantly less active compound than labeled; others varied substantially across lots.
FDA's GRN 791 letter says it has no questions, not that urolithin A is proven or approved
No questions at this time
FDA has no questions about the notifier's conclusion that urolithin A is GRAS under its intended conditions of use.
Not an affirmation
The letter states it is not an affirmation that urolithin A is GRAS.
Food ingredient uses
Protein shakes, bars, oatmeal and yogurt drinks at up to 500 mg per serving, and yogurts and milk-based shakes up to 1000 mg per serving.
Health claims
FDA's food additive office did not evaluate any information on labeling claims, so the letter says nothing about benefits.
GRN 791 is a food-use safety notice response, not an endorsement of any supplement's benefits.
FDA's inventory lists the closure status as: FDA has no questions. Source: U.S. Food and Drug Administration 2018.
Embed this chart
Free to reuse on your site. Copy the code below; please keep the credit link.
This is not a minor issue. If the effective dose explored in human studies is 500 mg per day and the supplement you are taking contains only a fraction of that amount, you are unlikely to experience the same biological effects. Choosing brands that publish independent third-party certificates of analysis from accredited laboratories is one of the few practical ways a consumer can verify label accuracy before purchase. A company’s own internal testing is not a substitute.
Bioavailability and Formulation: Why Delivery Method Matters
Even when a supplement contains the correct amount of urolithin A, how well your body absorbs it matters. UA is a relatively lipophilic compound, and standard powder or capsule forms may have limited oral bioavailability. Research has explored encapsulation technologies to address this. A comparative study on liposome-encapsulated UA found that this delivery format significantly improved the compound’s stability, bioaccessibility, and bioavailability compared to free-form UA [4].
Newer nanoparticle formulations have shown similar advantages in preclinical models [8], though these remain largely in research settings rather than widely available commercial supplements. For consumers, a practical question is whether a product uses any validated delivery technology, and whether the company can point to data supporting that choice rather than simply using phrases like ‘enhanced absorption’ without evidence.
Crystalline or spray-dried forms of UA are the most common in commercial products today. These have been studied at the preclinical and early clinical level [1], and direct UA supplementation sidesteps the microbiome conversion issue entirely. The key is verifying that the chosen form is present in adequate quantities and that the manufacturer has performed stability testing to confirm potency over the product’s shelf life.
Dosing: What Human Studies Have Used as Reference Points
The most referenced human clinical data on urolithin A used 500 mg and 1,000 mg per day, and the signals reported were secondary biomarker outcomes in company-funded trials [1][9]. This gives you a practical benchmark: products offering far lower doses per serving than these study doses have weaker scientific grounding, even if the ingredients are otherwise genuine.
It is also worth noting that UA research has focused primarily on middle-aged to older adults. Most mechanistic and safety work has not been conducted across the full range of ages or health conditions. The safety profile observed in the published human trial was favorable, with no serious adverse events reported at doses up to 1000 mg per day [1], but this does not mean every person will respond identically, and longer-term high-dose data remain limited.
A Practical Checklist for Evaluating Any Urolithin A Supplement
Given what the research shows, here is a framework for assessing a UA product. First, verify the ingredient: the label should list urolithin A by that name, not just ‘pomegranate extract,’ which may contain only ellagitannin precursors and cannot guarantee UA delivery in individuals whose microbiomes lack the converting bacteria [6]. Second, require third-party testing. Look for a certificate of analysis from an independent accredited lab, given the documented label accuracy problems in this supplement category [2].
Third, assess the dose against published human study benchmarks. Products supplying meaningfully less than 500 mg per serving have limited clinical literature behind them [1]. Fourth, ask about formulation. Whether a company uses standard crystalline UA, a liposomal system, or another delivery format, they should be able to explain the rationale and ideally point to data supporting absorption claims [4]. Fifth, treat any disease or anti-aging guarantee as a red flag. UA research is ongoing and promising, but no urolithin A supplement is approved to treat, cure, or prevent any medical condition.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
Urolithin A supplements are not approved to diagnose, treat, cure, or prevent any medical condition, and long-term safety data in humans across diverse populations remain limited. People who are pregnant, nursing, taking prescription medications, or managing chronic health conditions should consult a qualified healthcare provider before starting urolithin A or any new supplement.
Frequently Asked Questions
Can I get enough urolithin A from eating pomegranates or other foods?
Only if your gut microbiome contains the bacteria needed to convert ellagitannins into UA, and research shows a meaningful proportion of adults lack these strains [3]. For those without the right microbial profile, eating a pomegranate-rich diet may not meaningfully raise circulating UA levels. This is the core scientific rationale for pre-formed UA supplements.
What dose of urolithin A has been used in human studies?
A published clinical trial tested doses of 250 mg, 500 mg, and 1000 mg per day, with the higher two doses producing the most consistent evidence of mitochondrial gene expression changes [1]. Products falling significantly below these doses have less clinical reference to support their efficacy claims.
Are urolithin A supplements accurately labeled?
Not always. A 2024 analysis testing UA and related supplement products found discrepancies between stated label amounts and actual measured content [2]. This makes third-party verified certificates of analysis an important quality signal when choosing a product, rather than relying solely on what the label states.
Does the form of urolithin A, liposomal versus standard, make a difference?
Research comparing liposome-encapsulated UA to free-form UA found the liposomal format improved stability, bioaccessibility, and bioavailability in a controlled study [4]. Whether this difference produces meaningfully different clinical outcomes at typical commercial doses has not been definitively established. Standard crystalline forms used in the main safety and efficacy human trial also showed measurable biological effects [1].
Is urolithin A safe to take?
A human clinical trial reported no serious adverse events at doses up to 1000 mg per day and described UA as safe with a molecular signature of improved mitochondrial and cellular health [1]. However, this was a relatively short-term controlled study, and long-term safety data in diverse populations are still limited. People with medical conditions or who take prescription medications should consult a healthcare provider before adding any new supplement.
What health benefits does the current research actually support?
Early human and preclinical evidence points to changes in some mitochondrial biomarkers, mostly as secondary outcomes [1], muscle endurance gains on secondary endpoints in two company-funded trials that missed their primary endpoints [9][10][7], and, in a small heart-failure trial, no significant change in heart function [13][5]. These findings are biologically meaningful but preliminary. UA is not approved to treat any disease, and effects on hard clinical endpoints (such as muscle strength outcomes, cardiovascular events, or lifespan) remain under active investigation.
References
- Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism (2019). PMID 32694802
- Sandalova E et al. Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim. GeroScience (2024). PMID 38935229
- Yuan H et al. Urolithin A From Gut Metabolite to Therapeutic Agent: Bioavailability, Mechanisms, and Translational Insights. Journal of food science (2026). PMID 41866331
- Hu Y et al. Liposomes encapsulation by pH driven improves the stability, bioaccessibility and bioavailability of urolithin A: A comparative study. International journal of biological macromolecules (2023). PMID 37865359
- Liu S et al. Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers. iScience (2025). PMID 40034121
- Zhang M et al. Ellagic acid and intestinal microflora metabolite urolithin A: A review on its sources, metabolic distribution, health benefits, and biotransformation. Critical reviews in food science and nutrition (2023). PMID 35142569
- Broome SC et al. Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. Sports medicine (Auckland, N.Z.) (2024). PMID 39060742
- Zhang L et al. Gum arabic-coated urolithin A liposome nanoparticles: Fabrication, characterization, bioavailability and improved alleviation on NAFLD activity in vivo. Carbohydrate polymers (2026). PMID 42097775
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
- Kuerec AH et al. Targeting aging with urolithin A in humans: A systematic review. Ageing research reviews (2024). PMID 39002645
- Singh A et al. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. European journal of clinical nutrition (2022). PMID 34117375
- Jamialahmadi T et al. Evaluation of Urolithin A Efficacy in Heart Failure Patients with Reduced Ejection Fraction: A Randomized, Double-blind, Crossover, Placebo-controlled Clinical Trial. Reviews on recent clinical trials (2024). PMID 38415449
- Timeline (Amazentis) How to select the most effective urolithin A supplement. Timeline (Amazentis) (2026). source
- Mena P et al. Gastrointestinal stability of urolithins: an in vitro approach. European journal of nutrition (2017). PMID 26439723
- U.S. Food and Drug Administration Agency Response Letter GRAS Notice No. GRN 000791. U.S. Food and Drug Administration (2018). source
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.